0 XP   0   0   0

4BASEBIO UK SOCIETAS










Financial Health of 4basebio




Comparing to competitors in the Biotechnology industry




  Industry Rankings  


4BASEBIO UK SOCIETAS
Buy, Hold or Sell?

Should you buy, hold or sell 4basebio?

I guess you are interested in 4BASEBIO UK SOCIETAS. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse 4basebio

Let's start. I'm going to help you getting a better view of 4BASEBIO UK SOCIETAS. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is 4BASEBIO UK SOCIETAS even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how 4BASEBIO UK SOCIETAS is doing in the market. If the company is worth buying. The latest step is to find out how other investors value 4BASEBIO UK SOCIETAS. The closing price on 2022-12-08 was p700.00 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
4BASEBIO UK SOCIETAS Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of 4BASEBIO UK SOCIETAS.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit 4basebio earns for each 1 of revenue.

  • Above 10% is considered healthy but always compare 4basebio to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that 0.00 for each 1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of 4BASEBIO UK SOCIETAS:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--223.6%+223.6%
TTM--281.7%+281.7%
YOY--344.8%+344.8%
5Y--450.1%+450.1%
10Y--541.0%+541.0%
1.1.2. Return on Assets

Shows how efficient 4basebio is using its assets to generate profit.

  • Above 5% is considered healthy but always compare 4basebio to the Biotechnology industry mean.
  • -9.8% Return on Assets means that 4basebio generated -0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of 4BASEBIO UK SOCIETAS:

  • The MRQ is -9.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -7.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.8%TTM-7.2%-2.6%
TTM-7.2%YOY-5.0%-2.1%
TTM-7.2%5Y-5.7%-1.5%
5Y-5.7%10Y-5.7%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.8%-9.9%+0.1%
TTM-7.2%-8.9%+1.7%
YOY-5.0%-9.3%+4.3%
5Y-5.7%-11.7%+6.0%
10Y-5.7%-12.7%+7.0%
1.1.3. Return on Equity

Shows how efficient 4basebio is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare 4basebio to the Biotechnology industry mean.
  • -12.8% Return on Equity means 4basebio generated -0.13 for each 1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of 4BASEBIO UK SOCIETAS:

  • The MRQ is -12.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -9.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.8%TTM-9.0%-3.8%
TTM-9.0%YOY-3.1%-5.9%
TTM-9.0%5Y-6.0%-3.0%
5Y-6.0%10Y-6.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.8%-12.0%-0.8%
TTM-9.0%-11.5%+2.5%
YOY-3.1%-10.8%+7.7%
5Y-6.0%-14.2%+8.2%
10Y-6.0%-15.2%+9.2%

1.2. Operating Efficiency of 4BASEBIO UK SOCIETAS.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient 4basebio is operating .

  • Measures how much profit 4basebio makes for each 1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare 4basebio to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated 0.00  for each 1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of 4BASEBIO UK SOCIETAS:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--207.3%+207.3%
TTM--271.0%+271.0%
YOY--325.9%+325.9%
5Y--454.0%+454.0%
10Y--537.1%+537.1%
1.2.2. Operating Ratio

Measures how efficient 4basebio is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are 0.00 for each 1 in net sales.

Let's take a look of the Operating Ratio trends of 4BASEBIO UK SOCIETAS:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.871-2.871
TTM-3.504-3.504
YOY-3.604-3.604
5Y-5.132-5.132
10Y-6.371-6.371

1.3. Liquidity of 4BASEBIO UK SOCIETAS.

1.3. Liquidity
1.3.1. Current Ratio

Measures if 4basebio is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 4.25 means the company has 4.25 in assets for each 1 in short-term debts.

Let's take a look of the Current Ratio trends of 4BASEBIO UK SOCIETAS:

  • The MRQ is 4.254. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.621. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.254TTM5.621-1.367
TTM5.621YOY20.906-15.285
TTM5.6215Y12.050-6.429
5Y12.05010Y12.0500.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.2545.117-0.863
TTM5.6215.755-0.134
YOY20.9065.854+15.052
5Y12.0506.511+5.539
10Y12.0506.222+5.828
1.3.2. Quick Ratio

Measures if 4basebio is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare 4basebio to the Biotechnology industry mean.
  • A Quick Ratio of 3.52 means the company can pay off 3.52 for each 1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of 4BASEBIO UK SOCIETAS:

  • The MRQ is 3.518. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.573. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.518TTM2.573+0.945
TTM2.573YOY10.020-7.447
TTM2.5735Y7.109-4.536
5Y7.10910Y7.1090.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.5184.284-0.766
TTM2.5734.664-2.091
YOY10.0204.787+5.233
5Y7.1095.218+1.891
10Y7.1095.182+1.927

1.4. Solvency of 4BASEBIO UK SOCIETAS.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of 4basebio assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare 4basebio to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.23 means that 4basebio assets are financed with 23.4% credit (debt) and the remaining percentage (100% - 23.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of 4BASEBIO UK SOCIETAS:

  • The MRQ is 0.234. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.192. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.234TTM0.192+0.042
TTM0.192YOY0.562-0.370
TTM0.1925Y0.413-0.221
5Y0.41310Y0.4130.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2340.278-0.044
TTM0.1920.277-0.085
YOY0.5620.306+0.256
5Y0.4130.367+0.046
10Y0.4130.403+0.010
1.4.2. Debt to Equity Ratio

Measures if 4basebio is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare 4basebio to the Biotechnology industry mean.
  • A Debt to Equity ratio of 30.5% means that company has 0.31 debt for each 1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of 4BASEBIO UK SOCIETAS:

  • The MRQ is 0.305. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.240. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.305TTM0.240+0.065
TTM0.240YOY0.070+0.170
TTM0.2405Y0.157+0.083
5Y0.15710Y0.1570.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3050.315-0.010
TTM0.2400.317-0.077
YOY0.0700.319-0.249
5Y0.1570.403-0.246
10Y0.1570.462-0.305

2. Market Valuation of 4BASEBIO UK SOCIETAS

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every 1 in earnings 4basebio generates.

  • Above 15 is considered overpriced but always compare 4basebio to the Biotechnology industry mean.
  • A PE ratio of -43.09 means the investor is paying -43.09 for every 1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of 4BASEBIO UK SOCIETAS:

  • The EOD is -70.965. Company is losing money. -2
  • The MRQ is -43.086. Company is losing money. -2
  • The TTM is -76.795. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-70.965MRQ-43.086-27.879
MRQ-43.086TTM-76.795+33.710
TTM-76.795YOY-59.124-17.671
TTM-76.7955Y-60.776-16.020
5Y-60.77610Y-60.7760.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-70.965-8.986-61.979
MRQ-43.086-9.792-33.294
TTM-76.795-16.243-60.552
YOY-59.124-20.876-38.248
5Y-60.776-16.665-44.111
10Y-60.776-14.732-46.044

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of 4basebio is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 5.52 means the investor is paying 5.52 for each 1 in book value.

Let's take a look of the Price to Book Ratio trends of 4BASEBIO UK SOCIETAS:

  • The EOD is 9.087. Seems overpriced? -1
  • The MRQ is 5.517. Seems overpriced? -1
  • The TTM is 6.073. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD9.087MRQ5.517+3.570
MRQ5.517TTM6.073-0.556
TTM6.073YOY2.098+3.975
TTM6.0735Y4.070+2.003
5Y4.07010Y4.0700.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD9.0871.835+7.252
MRQ5.5172.006+3.511
TTM6.0732.774+3.299
YOY2.0983.453-1.355
5Y4.0702.713+1.357
10Y4.0702.402+1.668
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of 4BASEBIO UK SOCIETAS compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---17.909-7.968-56%54.455-133%11.005-263%11.005-263%
Book Value Growth--0.9850.9870%1.000-2%0.9890%0.9890%
Book Value Per Share--77.03793.960-18%54.455+41%69.250+11%69.250+11%
Book Value Per Share Growth---0.232-0.095-59%1.000-123%0.124-287%0.124-287%
Current Ratio--4.2545.621-24%20.906-80%12.050-65%12.050-65%
Debt To Asset Ratio--0.2340.192+22%0.562-58%0.413-43%0.413-43%
Debt To Equity Ratio--0.3050.240+27%0.070+333%0.157+94%0.157+94%
Dividend Per Share----0%-0%-0%-0%
Eps---9.864-8.149-17%-6.698-32%-6.791-31%-6.791-31%
Eps Growth----0.0770%-0.3850%-0.1790%-0.1790%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio9.087+39%5.5176.073-9%2.098+163%4.070+36%4.070+36%
Pe Ratio-70.965-65%-43.086-76.795+78%-59.124+37%-60.776+41%-60.776+41%
Price Per Share700.000+39%425.000576.250-26%396.000+7%442.429-4%442.429-4%
Price To Total Gains Ratio-39.085-65%-23.730-33.349+41%4.196-666%-20.834-12%-20.834-12%
Profit Growth---98.779-98.873+0%-99.249+0%-98.998+0%-98.998+0%
Quick Ratio--3.5182.573+37%10.020-65%7.109-51%7.109-51%
Return On Assets---0.098-0.072-27%-0.050-49%-0.057-42%-0.057-42%
Return On Equity---0.128-0.090-30%-0.031-76%-0.060-53%-0.060-53%
Total Gains Per Share---17.909-7.968-56%54.455-133%11.005-263%11.005-263%
Total Gains Per Share Growth---1.000-1.0000%1.000-200%-0.333-67%-0.333-67%
Usd Book Value--11586069.00014131243.500-18%8189857.500+41%10414955.571+11%10414955.571+11%
Usd Book Value Change Per Share---0.219-0.097-56%0.665-133%0.134-263%0.134-263%
Usd Book Value Per Share--0.9411.147-18%0.665+41%0.846+11%0.846+11%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.120-0.099-17%-0.082-32%-0.083-31%-0.083-31%
Usd Price Per Share8.547+39%5.1897.036-26%4.835+7%5.402-4%5.402-4%
Usd Profit---1483515.000-1225578.750-17%-1007325.000-32%-1021366.500-31%-1021366.500-31%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---0.219-0.097-56%0.665-133%0.134-263%0.134-263%
 EOD+2 -3MRQTTM+5 -19YOY+6 -195Y+6 -1910Y+6 -19

3.2. Fundamental Score

Let's check the fundamental score of 4BASEBIO UK SOCIETAS based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-70.965
Price to Book Ratio (EOD)Between0-19.087
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than13.518
Current Ratio (MRQ)Greater than14.254
Debt to Asset Ratio (MRQ)Less than10.234
Debt to Equity Ratio (MRQ)Less than10.305
Return on Equity (MRQ)Greater than0.15-0.128
Return on Assets (MRQ)Greater than0.05-0.098
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of 4BASEBIO UK SOCIETAS based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose700.000
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in GBP. All numbers in thousands.

Summary
Total Assets12,385
Total Liabilities2,896
Total Stockholder Equity9,489
 As reported
Total Liabilities 2,896
Total Stockholder Equity+ 9,489
Total Assets = 12,385

Assets

Total Assets12,385
Total Current Assets6,871
Long-term Assets6,871
Total Current Assets
Cash And Cash Equivalents 5,597
Net Receivables 85
Other Current Assets 1,126
Total Current Assets  (as reported)6,871
Total Current Assets  (calculated)6,808
+/- 63
Long-term Assets
Property Plant Equipment 3,488
Intangible Assets 1,695
Long-term Assets Other 331
Long-term Assets  (as reported)5,514
Long-term Assets  (calculated)5,514
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,615
Long-term Liabilities1,281
Total Stockholder Equity9,489
Total Current Liabilities
Accounts payable 664
Other Current Liabilities 951
Total Current Liabilities  (as reported)1,615
Total Current Liabilities  (calculated)1,615
+/-0
Long-term Liabilities
Other Liabilities 173
Deferred Long Term Liability 1,457
Long-term Liabilities  (as reported)1,281
Long-term Liabilities  (calculated)1,630
+/- 349
Total Stockholder Equity
Common Stock11,130
Retained Earnings -16,005
Other Stockholders Equity 14,364
Total Stockholder Equity (as reported)9,489
Total Stockholder Equity (calculated)9,489
+/-0
Other
Capital Stock11,130
Cash and Short Term Investments 5,597
Common Stock Shares Outstanding 12,317
Liabilities and Stockholders Equity 12,385
Net Debt -5,597
Net Invested Capital 9,489
Net Tangible Assets 9,251
Net Working Capital 5,256



Balance Sheet

Currency in GBP. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-06-302020-03-31
> Total Assets 
0
17,601
17,809
0
15,306
0
14,702
0
12,385
12,385014,702015,306017,80917,6010
   > Total Current Assets 
0
15,783
15,512
12,836
12,836
10,642
10,642
6,871
6,871
6,8716,87110,64210,64212,83612,83615,51215,7830
       Cash And Cash Equivalents 
0
15,003
15,001
0
12,064
0
9,586
0
5,597
5,59709,586012,064015,00115,0030
       Net Receivables 
0
289
39
120
120
604
46
85
85
858546604120120392890
       Other Current Assets 
0
636
380
551
671
68
900
1,041
1,126
1,1261,041900686715513806360
   > Long-term Assets 
0
1,817
2,297
0
2,470
0
4,060
0
5,514
5,51404,06002,47002,2971,8170
       Property Plant Equipment 
0
1,246
1,478
1,501
1,501
2,759
2,759
3,488
3,488
3,4883,4882,7592,7591,5011,5011,4781,2460
       Intangible Assets 
0
0
785
0
937
0
1,271
0
1,695
1,69501,2710937078500
       Other Assets 
0
3,635
0
872
872
1,134
30
1,788
1,788
1,7881,788301,13487287203,6350
> Total Liabilities 
0
17,601
2,351
0
1,891
0
3,007
0
2,896
2,89603,00701,89102,35117,6010
   > Total Current Liabilities 
0
787
813
614
614
1,523
1,523
1,615
1,615
1,6151,6151,5231,5236146148137870
       Short-term Debt 
0
716
416
0
0
0
432
0
0
004320004167160
       Short Long Term Debt 
0
716
349
0
0
0
356
0
0
003560003497160
       Accounts payable 
0
16
96
150
150
353
353
664
664
66466435335315015096160
       Other Current Liabilities 
0
55
301
241
464
1
738
589
951
9515897381464241301550
   > Long-term Liabilities 
0
2,669
1,538
0
1,277
0
1,484
0
1,281
1,28101,48401,27701,5382,6690
       Other Liabilities 
0
0
0
226
226
158
158
173
173
173173158158226226000
       Deferred Long Term Liability 
0
0
0
840
840
1,104
1,104
1,457
1,457
1,4571,4571,1041,104840840000
> Total Stockholder Equity
0
0
15,458
0
13,415
0
11,695
0
9,489
9,489011,695013,415015,45800
   Common Stock
0
0
11,130
11,130
11,130
11,130
11,130
11,130
11,130
11,13011,13011,13011,13011,13011,13011,13000
   Retained Earnings Total Equity000000000
   Accumulated Other Comprehensive Income 000000000
   Capital Surplus 000000000
   Treasury Stock000000000
   Other Stockholders Equity 
0
0
14,668
13,534
14,240
13,434
14,140
13,658
14,364
14,36413,65814,14013,43414,24013,53414,66800



Balance Sheet

Currency in GBP. All numbers in thousands.




Cash Flow

Currency in GBP. All numbers in thousands.




Income Statement

Currency in GBP. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue338
Cost of Revenue-69
Gross Profit269269
 
Operating Income (+$)
Gross Profit269
Operating Expense-3,457
Operating Income-3,527-3,188
 
Operating Expense (+$)
Research Development1,438
Selling General Administrative694
Selling And Marketing Expenses78
Operating Expense3,4572,210
 
Net Interest Income (+$)
Interest Income-
Interest Expense-113
Net Interest Income-113-113
 
Pretax Income (+$)
Operating Income-3,527
Net Interest Income-113
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-3,640-3,414
EBIT - interestExpense = -3,640
-3,640
-3,122
Interest Expense113
Earnings Before Interest and Taxes (ebit)-3,527-3,527
Earnings Before Interest and Taxes (ebitda)-3,207
 
After tax Income (+$)
Income Before Tax-3,640
Tax Provision--405
Net Income From Continuing Ops-3,235-3,235
Net Income-3,235
Net Income Applicable To Common Shares-3,235
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses3,526
Total Other Income/Expenses Net-113113
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
QLRD.TA
now

I found you a STOCH Bullish Reversal Divergence on the daily chart of QLRD.TA.

QLRD.TA Daily Candlestick Chart
SMAG.TA
1 minute ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SMAG.TA.

SMAG.TA Daily Candlestick Chart
GIX.TA
3 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of GIX.TA.

GIX.TA Daily Candlestick Chart
SCC.TA
4 minutes ago

I found you a Three Black Crows Candle Pattern on the daily chart of SCC.TA.

SCC.TA Daily Candlestick Chart
TPGM.TA
4 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of TPGM.TA.

TPGM.TA Daily Candlestick Chart
SPDV.TA
5 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of SPDV.TA.

SPDV.TA Daily Candlestick Chart
MYSZ.TA
6 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MYSZ.TA.

MYSZ.TA Daily Candlestick Chart
NRGN.TA
8 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of NRGN.TA.

NRGN.TA Daily Candlestick Chart
MIFT.TA
8 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of MIFT.TA.

MIFT.TA Daily Candlestick Chart
HUMX.TA
11 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of HUMX.TA.

HUMX.TA Daily Candlestick Chart
HROD.TA
11 minutes ago

I found you a RSI Bearish Hidden Divergence on the daily chart of HROD.TA.

HROD.TA Daily Candlestick Chart
G107.TA
12 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of G107.TA.

G107.TA Daily Candlestick Chart
ENDY.TA
14 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of ENDY.TA.

ENDY.TA Daily Candlestick Chart
ELWS.TA
14 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of ELWS.TA.

ELWS.TA Daily Candlestick Chart
DORL.TA
14 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of DORL.TA.

DORL.TA Daily Candlestick Chart
ALMO.TA
17 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ALMO.TA.

ALMO.TA Daily Candlestick Chart
ALLT.TA
17 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ALLT.TA.

ALLT.TA Daily Candlestick Chart
AICS.TA
18 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of AICS.TA.

AICS.TA Daily Candlestick Chart
XUEM.LSE
21 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of XUEM.LSE.

XUEM.LSE Daily Candlestick Chart
XMEU.LSE
24 minutes ago

I found you a Golden Cross on the daily chart of XMEU.LSE.

XMEU.LSE Daily Candlestick Chart
XLIS.LSE
24 minutes ago

I found you a Golden Cross on the daily chart of XLIS.LSE.

XLIS.LSE Daily Candlestick Chart
WELSPLSOL.BSE
32 minutes ago

I found you a Golden Cross on the daily chart of WELSPLSOL.BSE.

WELSPLSOL.BSE Daily Candlestick Chart
VTU.LSE
34 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VTU.LSE.

VTU.LSE Daily Candlestick Chart
VIC.LSE
37 minutes ago

I found you a Golden Cross on the daily chart of VIC.LSE.

VIC.LSE Daily Candlestick Chart